Delivery Order SPE2DB22D3004-SPE2DB25FPH00

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1004|SPE2DB22FF8T1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $3,441.70. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX7ZG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,474.62, is a Firm Fixed Price Delivery Order for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, with the ID SPE2DB20D1109|SPE2DB23FN97D, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract, which is a delivery order, covers the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The ceiling value of the contract is $9,815.90, and it has a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNM25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with an ultimate completion date of November 14, 2024 and a ceiling value of $4,278.71. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a...
This federal contract award, with an ID of SPE2DB22D3009|SPE2DB24FBE02, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $7,976.34 and a completion date of August 27, 2024. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTGH4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,603.60, is a Firm Fixed Price Delivery Order for the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This federal contract award, with ID SPE2DB25D3306|SPE2DB25FUANH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, with a total ceiling value of $3,201.38 and a completion date of January 13, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with ID SPE2DB20D2001|SPE2DB25FPMCR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $5,232.14. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 3, 2025. This award is not...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMFWZ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price of $5,574.48 and a completion date of January 14, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, with an ID of SPE2DB24D2010|SPE2DB24FZXB4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $8,389.91 and is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of August 19, 2024. The contract is not designated as a set-aside. Amerisourcebergen, through its Corporate Office...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPH00
    Delivery Order

This federal contract award, with the ID SPE2DB22D3004|SPE2DB25FPH00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $4,339.34 and a completion date of January 29, 2025. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the DLA Troop Support Medical. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 9:53 AM